NGM BIOPHARMACEUTICALS INC Operating Expenses
NGM BIOPHARMACEUTICALS INC reported Operating Expenses of $155.88 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-11.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2024-03-11
- NGM BIOPHARMACEUTICALS INC operating expenses for the quarter ending 2023-12-31 was $29.83M, a 47.19% decline year-over-year.
- NGM BIOPHARMACEUTICALS INC operating expenses for the quarter ending 2023-09-30 was $31.61M, a 43.76% decline year-over-year.
- NGM BIOPHARMACEUTICALS INC operating expenses for the quarter ending 2023-06-30 was $42.00M, a 24.14% decline year-over-year.
- NGM BIOPHARMACEUTICALS INC operating expenses for the quarter ending 2023-03-31 was $52.44M, a 2.03% decline year-over-year.
- NGM BIOPHARMACEUTICALS INC operating expenses for fiscal 2023 was $155.88M, a 29.65% decline from fiscal 2022.
- NGM BIOPHARMACEUTICALS INC operating expenses for fiscal 2022 was $221.58M, a 11.58% increase from fiscal 2021.
- NGM BIOPHARMACEUTICALS INC operating expenses for fiscal 2021 was $198.58M, a 3.86% increase from fiscal 2020.
- NGM BIOPHARMACEUTICALS INC operating expenses for fiscal 2020 was $191.20M, a 25.06% increase from fiscal 2019.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2023-12-31 | $29.83M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | $61.44M derived: sum of 2 quarters · filed 2024-03-11 | $103.44M derived: sum of 3 quarters · filed 2024-03-11 | $155.88M 10-K · filed 2024-03-11 |
| 2023-09-30 | $31.61M 10-Q · filed 2023-11-02 | $73.61M derived: sum of 2 quarters · filed 2023-11-02 | $126.05M 10-Q · filed 2023-11-02 | $182.53M derived: sum of 4 quarters · filed 2024-03-11 |
| 2023-06-30 | $42.00M 10-Q · filed 2023-08-03 | $94.44M 10-Q · filed 2023-08-03 | $150.92M derived: sum of 3 quarters · filed 2024-03-11 | $207.13M derived: sum of 4 quarters · filed 2024-03-11 |
| 2023-03-31 | $52.44M 10-Q · filed 2023-05-04 | $108.92M derived: sum of 2 quarters · filed 2024-03-11 | $165.13M derived: sum of 3 quarters · filed 2024-03-11 | $220.49M derived: sum of 4 quarters · filed 2024-03-11 |
| 2022-12-31 | $56.48M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | $112.69M derived: sum of 2 quarters · filed 2024-03-11 | $168.05M derived: sum of 3 quarters · filed 2024-03-11 | $221.58M 10-K · filed 2024-03-11 |
| 2022-09-30 | $56.22M 10-Q · filed 2023-11-02 | $111.58M derived: sum of 2 quarters · filed 2023-11-02 | $165.10M 10-Q · filed 2023-11-02 | $213.29M derived: sum of 4 quarters · filed 2024-03-11 |
| 2022-06-30 | $55.36M 10-Q · filed 2023-08-03 | $108.89M 10-Q · filed 2023-08-03 | $157.07M derived: sum of 3 quarters · filed 2024-03-11 | $204.65M derived: sum of 4 quarters · filed 2024-03-11 |
| 2022-03-31 | $53.53M 10-Q · filed 2023-05-04 | $101.71M derived: sum of 2 quarters · filed 2024-03-11 | $149.29M derived: sum of 3 quarters · filed 2024-03-11 | $202.69M derived: sum of 4 quarters · filed 2024-03-11 |
| 2021-12-31 | $48.18M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | $95.76M derived: sum of 2 quarters · filed 2024-03-11 | $149.16M derived: sum of 3 quarters · filed 2024-03-11 | $198.58M 10-K · filed 2024-03-11 |
| 2021-09-30 | $47.58M 10-Q · filed 2022-11-03 | $100.97M derived: sum of 2 quarters · filed 2022-11-03 | $150.39M 10-Q · filed 2022-11-03 | $197.83M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $53.39M 10-Q · filed 2022-08-04 | $102.81M 10-Q · filed 2022-08-04 | $150.25M derived: sum of 3 quarters · filed 2023-02-28 | $203.69M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $49.42M 10-Q · filed 2022-05-05 | $96.86M derived: sum of 2 quarters · filed 2023-02-28 | $150.30M derived: sum of 3 quarters · filed 2023-02-28 | $195.59M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $47.44M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $100.88M derived: sum of 2 quarters · filed 2023-02-28 | $146.17M derived: sum of 3 quarters · filed 2023-02-28 | $191.20M 10-K · filed 2023-02-28 |
| 2020-09-30 | $53.44M 10-Q · filed 2021-11-04 | $98.73M derived: sum of 2 quarters · filed 2021-11-04 | $143.76M 10-Q · filed 2021-11-04 | $192.14M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $45.29M 10-Q · filed 2021-08-05 | $90.32M 10-Q · filed 2021-08-05 | $138.70M derived: sum of 3 quarters · filed 2022-03-01 | $173.26M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $45.03M 10-Q · filed 2021-05-06 | $93.41M derived: sum of 2 quarters · filed 2022-03-01 | $127.98M derived: sum of 3 quarters · filed 2022-03-01 | $163.02M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $48.38M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $82.94M derived: sum of 2 quarters · filed 2022-03-01 | $117.99M derived: sum of 3 quarters · filed 2022-03-01 | $152.88M 10-K · filed 2022-03-01 |
| 2019-09-30 | $34.56M 10-Q · filed 2020-11-12 | $69.61M derived: sum of 2 quarters · filed 2020-11-12 | $104.51M 10-Q · filed 2020-11-12 | $138.57M derived: sum of 4 quarters · filed 2021-03-15 |
| 2019-06-30 | $35.05M 10-Q · filed 2020-08-12 | $69.94M 10-Q · filed 2020-08-12 | $104.00M derived: sum of 3 quarters · filed 2021-03-15 | $133.29M derived: sum of 4 quarters · filed 2021-03-15 |
| 2019-03-31 | $34.89M 10-Q · filed 2020-05-13 | $68.96M derived: sum of 2 quarters · filed 2021-03-15 | $98.24M derived: sum of 3 quarters · filed 2021-03-15 | $124.55M derived: sum of 4 quarters · filed 2021-03-15 |
| 2018-12-31 | $34.06M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $63.35M derived: sum of 2 quarters · filed 2021-03-15 | $89.65M derived: sum of 3 quarters · filed 2021-03-15 | $112.98M 10-K · filed 2021-03-15 |
| 2018-09-30 | $29.28M 10-Q · filed 2019-11-12 | $55.59M derived: sum of 2 quarters · filed 2019-11-12 | $78.92M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $26.30M 10-Q · filed 2019-08-12 | $49.63M 10-Q · filed 2019-08-12 | ||
| 2018-03-31 | $23.33M 10-Q · filed 2019-05-16 | |||
| 2017-12-31 | $94.57M 10-K · filed 2020-03-17 |